MONTREAL, QUEBEC--(Marketwire - May 08, 2008) - Adaltis Inc. (TSX: ADS), an international in vitro diagnostic (IVD) company, today reported its first quarter 2008 financial results and the formal closing of the sale of its European assets to a European-based company.
